ArtNr |
HY-12326B-25mg |
Hersteller |
MedChem Express
|
Menge |
25 mg |
Quantity options |
10 mg
1 mg
25 mg
500 ug
50 mg
5 mg
|
Kategorie |
|
Typ |
Reagents |
Specific against |
other |
Purity |
99.36 |
Formula |
C20H30N12O12P2 |
Citations |
[1]Fahmi T, et al. c-di-AMP: An Essential Molecule in the Signaling Pathways that Regulate the Viability and Virulenceof Gram-Positive Bacteria. Genes (Basel). 2017 Aug 7;8(8).<br/>[2]Ning H, et al. Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous AdjuvantInduces Elevated Immune Responses After Mycobacterium tuberculosis Infection. Front Immunol. 2019 Jul 3;10:1519.<br/>[3]Ebensen T, et al. The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and QualitativeEnhanced Immune Responses Post Immunization. Front Cell Infect Microbiol. 2019 Feb 19;9:31.<br/>[4]Sanchez MV, et al. Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellularimmune responses and provides protection against virus challenge. PLoS One. 2014 Aug 20;9(8):e104824. |
Smiles |
O[C@H]([C@@](OP(O)(OC[C@](O[C@@H](N1C2=NC=NC(N)=C2N=C1)[C@@H]3O)([H])[C@@]3([H])O4)=O)([H])[C@](COP4(O)=O)([H])O5)[C@@H]5N6C7=NC=NC(N)=C7N=C6.N.N |
ECLASS 10.1 |
42051003 |
ECLASS 11.0 |
42051003 |
UNSPSC |
12000000 |
Alias |
Cyclic diadenylate (diammonium); Cyclic-di-AMP (diammonium) |
Lieferbar |
|
Product Description |
c-di-AMP diammonium is a STING agonist, which binds to the transmembrane protein STING thereby activating the TBK3-IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF. c-di-AMP diammonium is also a bacterial second messenger, which regulates cell growth, survival, and virulence, primarily within Gram-positive bacteria, and also regulates host immune response. c-di-AMP diammonium acts as a potent mucosal adjuvant stimulating both humoral and cellular responses[1][2][3][4]. |
StorageTemperature |
-20°C (Powder, sealed storage, away from moisture) |
Shipping |
Blue Ice |
Manufacturers Applications |
COVID-19-immunoregulation |
MolecularWeight |
692.47 |
Clinical Information |
No Development Reported |
Manufacturers Research Area |
Inflammation/Immunology |
Solubility |
DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |
Target |
Bacterial; Endogenous Metabolite; STING |
Manufacturers Target |
Bacterial; Endogenous Metabolite; STING |
Manufacturers Pathway |
Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease |
Manufacturers Product type |
Reference compound |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.